Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression-Reference-Cited by-同舟云学术

Cost-Effectiveness of Repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for Treatment-Resistant Depression

Published:2015-07 Issue:5 Volume:18 Page:597-604
ISSN:1098-3015
Container-title:Value in Health
language:en
Short-container-title:Value in Health

Author:

Nguyen Kim-Huong,Gordon Louisa G.

Publisher

Elsevier BV

Subject

Public Health, Environmental and Occupational Health,Health Policy

Reference26 articles.

1. The increasing burden of depression;Lepine;Neuropsychiatr Dis Treat,2011

2. A review of the clinical, economic, and societal burden of treatment-resistant depression: 1996–2013;Mrazek;Psychiatr Serv,2014

3. The burden of recurrent depression: causes, consequences, and future prospects;Greden;J Clin Psychiatry,2001

4. Transcranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of acute treatment outcomes in clinical practice;Carpenter,2012

5. Repetitive transcranial magnetic stimulation for major depressive disorder: a review;Daskalakis;Can J Psychiatry,2008

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Should rTMS be considered a first-line treatment for major depressive episodes in adults?;Clinical Neurophysiology;2024-09

2. Positioning rTMS Within a Sequential Treatment Algorithm of Depression;American Journal of Psychiatry;2024-09-01

3. Fluoxetin suppresses tau phosphorylation and modulates the interaction between tau and tubulin in the hippocampus of CUMS rats;Neuroscience Letters;2024-07

4. Patient-Informed Value Elements in Cost-Effectiveness Analyses of Major Depressive Disorder Treatment: A Literature Review and Synthesis;Value in Health;2024-06

5. Depressive symptom trajectories with prolonged rTMS treatment;Brain Stimulation;2024-05